EQS-News: Alzchem Group AG reports 36.4% EBITDA growth to EUR 76.8 million – strong earnings performance continues in the first nine months of 2024
Source: EQS
Trostberg, The The consolidated result for the period rose significantly by 65.6% to Within the individual application areas, Human Nutrition (Creapure®), Animal Nutrition (Creamino®) and Defense (Nitroguanidine) performed particularly well. Products in the Pharma (Bioselect®, due to the general trend towards customized, individually tailored DNA analysis) and Automotive (DYHARD®, due to its increasing use in lightweight construction) segments also enjoyed strong demand. In addition, the agriculture segment recorded a positive trend with the fertilizer Perlka® as a result of a significant recovery in demand. By contrast, the Custom Manufacturing segment (multi-purpose plants) due to the effects of the general chemical industry and the NITRALZ® business due to the highly price-driven competition from For the fiscal year 2024, consolidated sales are expected to grow to around The detailed quarterly statement is available for download on the website www.alzchem.com in the Investors/Publications section. About Alzchem Alzchem is a globally active specialty chemicals company that is one of the market leaders in most of its fields of activity. Alzchem offers answers to various global developments such as climate change, population growth and increasing life expectancy. We deliver solutions through brands and products of the highest quality and through a sustainable vision to help shape global developments. The company sees interesting growth prospects for itself in the areas of human and animal nutrition and agriculture in particular. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and creatine products can contribute to a healthy old age as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective. Alzchem Group AG’s broad product range includes dietary supplements, precursors for PCR tests and pharmaceutical raw materials. These offerings are the company’s response to global trends and developments. Alzchem is ideally positioned in this respect and considers itself well prepared for an environmental future and global developments. The company employs around 1,690 people at four production sites in
|
Language: | English |
Company: | |
Dr.-Albert-Frank-Str. 32 | |
83308 Trostberg | |
Phone: | +498621862888 |
Fax: | +49862186502888 |
E-mail: | ir@alzchem.com |
Internet: | www.alzchem.com |
ISIN: | DE000A2YNT30 |
WKN: | A2YNT3 |
Indices: | SDAX |
Listed: | Regulated Market in |
EQS News ID: | 2024343 |
End of News |
|
2024343 07.11.2024 CET/CEST